Barbara Bishop
Family Medicine · San Francisco, CANPI 1144302126
Payments from drug & device makers
Across 288 payments — averaging $26.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$2K
- Novo Nordisk$820
- Pfizer$653
- Astellas Pharma US Inc$404
- Amgen$349
- EMD Serono, Inc.$277
- plus $3K from 32 others
What the payments were for
- Speaking & faculty fees$1,50620%
- Travel & lodging$5768%
- Food & beverage$5,48072%
- Education$1001%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 10 | $2,232 |
| Novo Nordisk | 64 | $820 |
| Pfizer | 30 | $653 |
| Astellas Pharma US Inc | 17 | $404 |
| Amgen | 15 | $349 |
| EMD Serono, Inc. | 6 | $277 |
| Otsuka America Pharmaceutical, Inc. | 17 | $260 |
| Boehringer Ingelheim | 12 | $246 |
| Lilly USA, LLC | 14 | $234 |
| E.r. Squibb & Sons, L.L.C. | 9 | $212 |
| AstraZeneca | 12 | $207 |
| Sunovion Pharmaceuticals Inc. | 11 | $169 |
| Mylan Specialty L.p. | 6 | $160 |
| Johnson & Johnson | 7 | $158 |
| Eisai Inc. | 7 | $135 |
| Merck | 5 | $103 |
| Sumitomo Pharma America, Inc. | 5 | $101 |
| AbbVie | 4 | $97 |
| Amarin Pharma, Inc. | 5 | $92 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $86 |
| GSK | 3 | $85 |
| Novartis | 2 | $65 |
| Bausch Health US, LLC | 3 | $62 |
| Radius Health, Inc. | 3 | $57 |
| Myriad Women's Health, Inc. | 1 | $57 |
| Bayer | 2 | $50 |
| Abbott | 2 | $46 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $44 |
| Teva Pharmaceuticals USA, Inc. | 1 | $30 |
| Hologic Sales And Service, LLC | 1 | $25 |
| Xeris Pharmaceuticals, Inc. | 1 | $23 |
| Gilead | 1 | $23 |
| Exact Sciences | 1 | $19 |
| Medtronic | 1 | $18 |
| Biodelivery Sciences International, Inc. | 1 | $16 |
| Acell, Inc. | 1 | $16 |
| Seqirus USA Inc | 1 | $15 |
| Mallinckrodt Enterprises LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AUBAGIO$2,018
How this compares
$7,662 in reported general payments places this provider in the 90th percentile of 10,533 family medicine providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 23 | $23,194 |
| JanuviaSitagliptin Phosphate | 13 | $19,961 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 12 | $1,950 |
| Atorvastatin Calcium | 132 | $1,397 |
| Celecoxib | 13 | $1,022 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 26 | $954 |
| Levothyroxine Sodium | 59 | $852 |
| Losartan Potassium | 55 | $808 |
| Amlodipine Besylate | 86 | $761 |
| Metoprolol Succinate | 56 | $735 |
| Metformin Hcl ErMetformin Hcl | 29 | $711 |
| Metformin Hcl | 59 | $611 |
| Gabapentin | 37 | $592 |
| Omeprazole | 38 | $573 |
| Simvastatin | 29 | $379 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $653 | $23,19423 claims |
| MerckJanuvia | $103 | $19,96113 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 10,533 family medicine providers in California.
Other family medicine in San Francisco
- Amina HaggagNorthridge$112.8M
- Steven ReynoldsLong Beach$53M
- Rizwana MohseniLake Forest$26.7M
- Daniel JohnsonSan Diego$15.7M
- Stacey LayleSan Diego$14.8M
- Apinya VutikullirdCypress$14.3M
- Hanid AudishSpring Valley$13.6M
- Augusto FocilOxnard$12.6M
- Jack VuLong Beach$10.1M
- Suzanne FussellOxnard$8.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.